potential

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

2 months ago

Alghanim Industries Brings Starlink’s Groundbreaking Satellite Internet to Global Markets

To drive innovation, Alghanim Industries is unveiling Sama X, a bold new tech venture and authorized Starlink global reseller that brings…

2 months ago

ZeroError Launches Advanced Analytics Capabilities to Support Supply Chain Use Cases on Snowflake AI Data Cloud

SAN FRANCISCO--(BUSINESS WIRE)--ZeroError, today announced at Snowflake’s annual user conference, Snowflake Summit 2025, the launch of new advanced analytics capabilities…

2 months ago

DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer

TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and AstraZeneca’s DATROWAY with immunotherapy as first-line treatment for…

2 months ago

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting

TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to show a clinically meaningful and statistically significant improvement…

2 months ago

The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer

Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about…

2 months ago

DoorDash Announces Closing of Upsized $2.75 Billion Offering of 0% Convertible Senior Notes

Opportunistic capital raise with proceeds used to enhance strategic flexibility A portion of the proceeds used to purchase a hedge…

2 months ago